TriSalus Life Sciences, Inc. (TLSI)
$4.06-1.69%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $154M
- Beta
- 0.47
- P/E (TTM)
- -3.28
- Short % float
- 22.31%
- Days to cover
- 4.4
- SI change
- +0.0%
- 1W
- -6.02%
- 1M
- -13.62%
- vs SPY 1W
- -7.18%
- vs SPY 1M
- -16.61%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on TLSI?
- LOPJLB’s latest quantitative signal on TriSalus Life Sciences, Inc. (TLSI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is TLSI in?
- TriSalus Life Sciences, Inc. (TLSI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does TriSalus Life Sciences, Inc. (TLSI) do?
- TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusio…